Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin

被引：0
|
作者：
Pankaj Puar
Makoto Hibino
C. David Mazer
Andrew T. Yan
Arjun K. Pandey
Adrian Quan
Hwee Teoh
David A. Hess
Raj Verma
Kim A. Connelly
Subodh Verma
机构：
[1] St. Michael’s Hospital of Unity Health Toronto,Division of Cardiac Surgery
[2] Keenan Research Centre for Biomedical Science in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital,Department of Pharmacology and Toxicology
[3] University of Toronto,Faculty of Medicine
[4] University of British Columbia,Department of Cardiac Surgery
[5] University Hospitals Cleveland Medical Center,Department of Anesthesia
[6] Case Western Reserve University,Departments of Anesthesiology and Pain Medicine
[7] St. Michael’s Hospital of Unity Health Toronto,Department of Physiology
[8] University of Toronto,Division of Cardiology
[9] University of Toronto,Department of Medicine
[10] St. Michael’s Hospital of Unity Health Toronto,Michael G. DeGroote School of Medicine
[11] University of Toronto,Division of Endocrinology and Metabolism
[12] McMaster University,Molecular Medicine Research Laboratories, Krembil Centre for Stem Cells Biology, Robarts Research Institute
[13] St. Michael’s Hospital of Unity Health Toronto,Department of Physiology and Pharmacology
[14] University of Western Ontario,Department of Surgery
[15] University of Western Ontario,undefined
[16] Royal College of Surgeons in Ireland,undefined
[17] University of Toronto,undefined
来源：
Cardiovascular Diabetology | / 22卷
关键词：
SGLT2 inhibition; Diabetes; Heart failure; Cardiac reverse remodelling; Left ventricle;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin
    Puar, Pankaj
    Hibino, Makoto
    Mazer, C. David
    Yan, Andrew T.
    Pandey, Arjun K.
    Quan, Adrian
    Teoh, Hwee
    Hess, David A.
    Verma, Raj
    Connelly, Kim A.
    Verma, Subodh
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [2] Left Ventricular Mass Predicts Cardiac Reverse Remodeling in Patients With Type 2 Diabetes and Coronary Artery Disease Who Are Treated With Empagliflozin
    Puar, Pankaj
    Hibino, Makoto
    Teoh, Hwee
    Quan, Adrian
    Verma, Raj
    Mazer, David
    Yan, Andrew
    Connelly, Kim
    Verma, Subodh
    CIRCULATION, 2022, 146
  • [3] Left ventricular dyssynchrony assessed with radionuclide angiography predicts left ventricular reverse remodelling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy
    Dalle Mule, J
    Martinelli, F
    Proclemer, A
    Moro, E
    Mazzella, M
    Scrimieri, P
    CIRCULATION, 2004, 110 (17) : 656 - 656
  • [4] ANALYSIS OF LEFT VENTRICULAR REMODELLING IN PATIENTS TREATED WITH CARDIAC RESYNCHRONISATION THERAPY
    An, Zhe
    Zhang, Wenqi
    HEART, 2011, 97 : A181 - A181
  • [5] QRS duration shortening predicts left ventricular reverse remodelling in patients with dilated cardiomyopathy after cardiac resynchronization therapy
    Zhang, Jianghua
    Zhang, Yu
    Zhou, Xianhui
    Li, Jinxin
    Li, Yaodong
    Zhang, Yanyi
    Xu, Guojun
    Xing, Qiang
    Lin, Sun
    Tang, Baopeng
    ACTA CARDIOLOGICA, 2015, 70 (03) : 307 - 313
  • [6] Regional left ventricular rotation is altered by mechanical dyssynchrony and predicts reverse remodelling to cardiac resynchronization therapy
    Sade, L. E.
    Demir, O.
    Ozin, B.
    Eroglu, S.
    Pirat, B.
    Atar, I.
    Muderrisoglu, H.
    EUROPEAN HEART JOURNAL, 2008, 29 : 725 - 725
  • [7] Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling after cardiac resynchronization therapy
    Lancellotti, Patrizio
    Senechal, Mario
    Moonen, Marie
    Donal, Erwan
    Magne, Julien
    Nellessen, Eric
    Attena, Emilio
    Cosyns, Bernard
    Melon, Pierre
    Pierard, Luc
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2009, 10 (05): : 663 - 668
  • [8] Myocardial fibrosis at cardiovascular magnetic resonance predicts left ventricular reverse remodelling
    Barison, A.
    Ortalda, A.
    Todiere, G.
    Pescetelli, I.
    Mirizzi, G.
    Vergaro, G.
    Aquaro, G. D.
    Masci, P. G.
    Passino, C.
    Emdin, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1053 - 1054
  • [9] Cardiac mechanics as predictors of left ventricular reverse remodelling in patients with dilated non-ischemic cardiomyopathy
    Ferrandez, M.
    Islas, F.
    Travieso, A.
    Diz-Diaz, J.
    Restrepo, A.
    Goirigolzarri, J.
    Luaces, M.
    De Agustin, J. A.
    Bustos, A.
    Olmos, C.
    EUROPEAN HEART JOURNAL, 2021, 42 : 281 - 281
  • [10] The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy
    Di Biase, Luigi
    Auricchio, Angelo
    Sorgente, Antonio
    Civello, Kenneth
    Klersy, Catherine
    Faletra, Francesco
    Riedlbauchova, Lucie
    Patel, Dimpi
    Arruda, Mauricio
    Schweikert, Robert A.
    Martin, David O.
    Saliba, Walid I.
    Moccetti, Tiziano
    Wilkoff, Bruce L.
    Natale, Andrea
    EUROPEAN HEART JOURNAL, 2008, 29 (20) : 2497 - 2505
12345